A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
TrasGEX™: Phase 1 Study in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Ginseng on Cancer-Related Fatigue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
- Status
- TERMINATED
- Phase
- NA
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
- Status
- COMPLETED
- Phase
- N/A
A Study of LY2523355 in Patients With Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BIBF 1120 and RAD001 in Solid Tumors - Phase I
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
- Status
- COMPLETED
- Phase
- N/A
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
- Status
- COMPLETED
- Phase
- PHASE2
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1